RAXIBACUMAB- raxibacumab injection
Glaxo Operations UK Ltd
----------
PRINCIPAL DISPLAY PANEL
NDC 49401-104-01
RAXIBACUMAB
Injection
1700 mg/34mL
(50 mg/mL)
For Intravenous Infusion
Must be Diluted Prior To Use
Rx only
Single-Use Vial; Discard unused portion
ATTENTION: Confirm expiration date on carton prior to removing vial. Before use apply enclosed label to vial over the existing label.
34 mL
For Strategic National Stockpile Use Only
10000000115020 Rev. 3/13
RAXIBACUMAB
raxibacumab injection |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
RAXIBACUMAB
raxibacumab injection |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - Glaxo Operations UK Ltd (424738227) |